About the Authors
- Shahin Lockman
-
* E-mail: slockman@hsph.harvard.edu
Affiliations Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Harvard School of Public Health, Boston, Massachusetts, United States of America, Botswana Harvard School of Public Health AIDS Initiative Partnership, Gaborone, Botswana
- Michael Hughes
-
Affiliation Harvard School of Public Health, Boston, Massachusetts, United States of America
- Fred Sawe
-
Affiliation Kenya Medical Research Institute/Walter Reed Project and US Military HIV Research Program, Kericho, Kenya
- Yu Zheng
-
Affiliation Harvard School of Public Health, Boston, Massachusetts, United States of America
- James McIntyre
-
Affiliation Anova Health Institute, Johannesburg, South Africa
- Tsungai Chipato
-
Affiliation University of Zimbabwe, Harare, Zimbabwe
- Aida Asmelash
-
Affiliation Botswana Harvard School of Public Health AIDS Initiative Partnership, Gaborone, Botswana
- Mohammed Rassool
-
Affiliation University of Witwatersrand, Johannesburg, South Africa
- Sylvester Kimaiyo
-
Affiliation Moi University Faculty of Health Sciences, Eldoret, Kenya
- Douglas Shaffer
-
Affiliation Kenya Medical Research Institute/Walter Reed Project and US Military HIV Research Program, Kericho, Kenya
- Mina Hosseinipour
-
Affiliation Kamuzu Central Hospital, University of North Carolina Project, Lilongwe, Malawi
- Lerato Mohapi
-
Affiliation Chris Hani Baragwanath Hospital, Johannesburg, South Africa
- Francis Ssali
-
Affiliation Joint Clinical Research Centre, Kampala, Uganda
- Margret Chibowa
-
Affiliation University of Alabama at Birmingham Center for Infectious Disease Research in Zambia, Lusaka
- Farida Amod
-
Affiliation University of Kwazulu-Natal, Durban, South Africa
- Elias Halvas
-
Affiliation University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
- Evelyn Hogg
-
Affiliation Social & Scientific Systems, Silver Spring, Maryland, United States of America
- Beverly Alston-Smith
-
Affiliation National Institutes of Health, Bethesda, Maryland, United States of America
- Laura Smith
-
Affiliation Frontier Science and Technology Research Foundation, Amherst, Massachusetts, United States of America
- Robert Schooley
-
Affiliation University of California San Diego, San Diego, California, United States of America
- John Mellors
-
Affiliation University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
- Judith Currier
-
Affiliation University of California Los Angeles, Los Angeles, California, United States of America
- the OCTANE (Optimal Combination Therapy After Nevirapine Exposure) ACTG A5208/OCTANE Study Team
Competing Interests
M. Hughes reports receiving fees as a member of the data and safety monitoring boards for Boehringer Ingelheim, Medicines Development, Pfizer, Tibotec, and Virionyx and the receipt by his department of financial support from Schering-Plough and Merck for an annual educational workshop; J. McIntyre, receiving financial support from the Abbott Speakers Bureau; M. Hosseinipour, receiving financial support from Abbott Virology for educational presentations (M. Hosseinipour has given an educational lecture at the 2009 IAS conference and the 2010 INTEREST conference for Abbott virology on the topic of antiretroviral resistance in Malawi); L. Mohapi, receiving reimbursement for travel expenses from Pfizer Laboratories (L. Mohapi received travel, accommodation and registration assistance for the XVII AIDS Conference in Mexico City, August 2008, from Pfizer); J. Mellors, serving on the scientific advisory board for Gilead Sciences, receiving consulting fees from Merck, Idenix Pharmaceuticals, Chimerix, RFS Pharmaceuticals, Panacos Pharmaceuticals, and Abbott Laboratories, receiving grant support from Merck, having stock options in RFS Pharmaceuticals, and receiving reimbursement for travel expenses from Gilead Sciences, Merck, Chimerix, Idenix Pharmaceuticals, RFS Pharmaceuticals, and Panacos Pharmaceuticals; R. Schooley, receiving consulting fees from Glaxo-SmithKline and Abbott Laboratories and reimbursement for travel expenses from Abbott Laboratories (and serves on the scientific advisory board for Gilead Sciences); and J. Currier, receiving consulting fees from GlaxoSmithKline and grant support from Merck and Tibotec. All other authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: SL MHu FSa JMc TC AA DS MHo LM FA EHa BAS RS JMe JC. Analyzed the data: MHu EZ. Wrote the first draft of the manuscript: SL. Contributed to the writing of the manuscript: SL MHu EHo JMe JC. ICMJE criteria for authorship read and met: SL MHu FSa EZ JMc TC AA MR SK DS MHo LM FSs MC FA EHo EHa LS BAS RS JMe JC. Agree with manuscript results and conclusions: SL MHu FSa EZ JMc TC AA MR SK DS MHo LM FSs MC FA EHo EHa LS BAS RS JMe JC. Enrolled patients: FSa JMc TC AA MR SK DS MHo LM FSs FA. Data manager, case report forms: LS.